A new leukemia treatment by Terns Pharmaceuticals is showing promising results in clinical trials, surpassing expectations among medical professionals and investors. This development has boosted several small biotech firms, offering them renewed hope and investment opportunities.
Source: https://www.barrons.com/articles/cancer-study-drugs-stock-biotechs-a3afbfc5